MOVICOL

Dosage

Children: Refer to the specific active ingredient for appropriate dosing guidelines.

Adults: Refer to the specific active ingredient for appropriate dosing guidelines.

Mechanism of action

The mechanism of action varies depending on the specific active ingredient. Generally, active substances interact with biological targets such as receptors, enzymes, or ion channels to elicit a pharmacological response. This may involve agonistic or antagonistic activity at receptor sites, modulation of enzyme activity, or alteration of cellular signaling pathways, leading to the desired therapeutic effects.

Pharmacodynamics

Pharmacodynamics describes the effects of the active drug on the body, including the relationship between drug concentration, receptor binding, and the resultant biological effect. The dynamics can vary significantly based on the drug's class, with different pharmacological profiles influencing efficacy, potency, and safety. Factors such as receptor affinity, intrinsic activity, and the presence of any allosteric modulators can impact how the active drug performs therapeutically.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion (ADME) of the active drug. Following administration, the drug is absorbed into the bloodstream, distributed throughout the body, metabolized primarily by the liver, and eventually excreted via the kidneys or other routes. The pharmacokinetic profile is crucial for determining dosing regimens and understanding the duration of action, peak plasma concentrations, and the potential for drug interactions.

Pregnancy

Consult healthcare provider for potential risks versus benefits.

Breast-feeding

Consult healthcare provider as it may affect milk production or composition.

Storage

Store in a cool, dry place away from direct sunlight, and out of reach of children.

Indications

• Metabolic acidosis
• Acid-base imbalance
• Urinary alkalinization
• Treatment of certain poisonings
• Cardiac arrest in the context of metabolic acidosis

Dosage

Children: Refer to the BNF for Children for specific pediatric dosages, as they depend on the clinical condition

Adults: Refer to local guidelines and BNF for specific dosing recommendations as they may vary based on clinical condition and severity. General adult dosing for bicarbonate may range from 1 to 2 mEq/kg IV initially, followed by maintenance doses as needed.

Mechanism of action

Bicarbonate acts as a buffer that neutralizes excess acids in the body. It dissociates in solution to produce bicarbonate ions (HCO3-) which can react with hydrogen ions (H+) to form carbonic acid (H2CO3), subsequently leading to the production of carbon dioxide (CO2) and water (H2O). This process helps to raise the pH of the blood and other fluids, counteracting acidosis. Bicarbonate is involved in several metabolic pathways, including the urea cycle and various biosynthetic pathways.

Pharmacodynamics

Bicarbonate's primary pharmacodynamic effect is its ability to buffer hydrogen ions, thus increasing blood pH. This is essential in conditions such as metabolic acidosis, where the body accumulates excess acid. By raising blood pH, bicarbonate can help alleviate symptoms associated with acidemia, such as fatigue, confusion, and shortness of breath. Its effects can also influence the renal and respiratory systems to regulate acid-base homeostasis.

Pharmacokinetics

Bicarbonate is rapidly absorbed from the gastrointestinal tract. It is distributed throughout the body fluids, and its effects can be seen within minutes of administration. The kidneys play a significant role in bicarbonate homeostasis by reabsorbing bicarbonate from urine and excreting hydrogen ions. The elimination half-life can vary, depending on the patient's metabolic state and renal function.

Pregnancy

Use with caution. Consult with a healthcare provider before use.

Breast-feeding

Use with caution. Consult with a healthcare provider before use.

Storage

Store in a cool, dry place away from light.

Dosage

Children: Refer to specific drug information for detailed dosage recommendations.

Adults: Refer to specific drug information for detailed dosage recommendations.

Mechanism of action

The mechanism of action varies depending on the specific drug that 'contains' certain active ingredients. Each compound will have its own unique pharmacological pathway and target within the body, which can include receptor modulation, enzyme inhibition, or other biochemical interactions.

Pharmacodynamics

Pharmacodynamics will depend on the active ingredients in the formulation. It generally encompasses the biochemical and physiological effects of the drug and its mechanisms of action, including the relationship between drug concentration and effect.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion of the specific active ingredients within the formulation. This can vary significantly based on the drug's chemical properties, route of administration, and individual patient factors.

Pregnancy

Consult with a healthcare provider before use, as safety during pregnancy has not been established.

Breast-feeding

Consult with a healthcare provider before use, as it is not known if this drug is excreted in human milk.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Generalized anxiety disorder
• Panic disorder
• Social anxiety disorder
• Obsessive-compulsive disorder
• Depressive disorders

Dosage

Children: Refer to the BNF for Children for appropriate dosing recommendations.

Adults: Refer to specific dosing guidelines in the BNF or consult a healthcare professional for tailored dosing.

Mechanism of action

Following acts as a selective serotonin reuptake inhibitor (SSRI), which increases the levels of serotonin in the synaptic cleft by inhibiting its reuptake into the presynaptic neuron. This enhances serotonergic neurotransmission, which is believed to contribute to its anxiolytic and antidepressant effects. Additionally, it may have effects on norepinephrine reuptake, further contributing to its mood-stabilizing properties.

Pharmacodynamics

The pharmacodynamics of Following involve its interaction with serotonin receptors and the modulation of neurotransmitter release in the central nervous system. This results in altered mood, reduced anxiety, and improved emotional response. The onset of action for anxiolytic effects may take several weeks, as adaptive changes in receptor sensitivity and neurotransmitter levels occur over time.

Pharmacokinetics

Following is well absorbed after oral administration, with peak plasma concentrations typically reached within several hours. It is extensively metabolized in the liver, primarily by cytochrome P450 enzymes, and has a half-life that allows for once-daily dosing in most cases. Renal and hepatic function can significantly affect the drug's clearance, necessitating dosage adjustments in patients with impairment.

Pregnancy

Following has not been adequately studied in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether Following is excreted in human milk. Caution should be exercised when administered to a nursing mother.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Indications

• Constipation
• Bowel preparation for diagnostic procedures (e.g., colonoscopy)

Dosage

Children: For children, macrogol is typically used at a dose of 0.5 to 1 g/kg per day, not exceeding 17 g per day, depending on the child's age and condition. Refer to the BNF for Children for detailed pediatric dosing guidance.

Adults: Typical adult dosing for constipation is 8.4 grams of macrogol powder dissolved in water, taken once daily. For bowel preparation, specific dosing regimens may vary, and it is essential to follow product instructions or medical advice.

Mechanism of action

Macrogol works as an osmotic agent, drawing water into the bowel lumen through osmosis. This increased water content softens the stool, making it easier to pass. The presence of macrogol in the intestine increases the volume and viscosity of the stool, stimulating peristalsis and facilitating bowel evacuation.

Pharmacodynamics

Macrogol's laxative effect is dose-dependent, with higher doses generally resulting in more significant bowel movement stimulation. It is not absorbed systemically, which minimizes potential side effects and interactions. The osmotic effect leads to an increase in intraluminal pressure and stool volume, contributing to effective evacuation.

Pharmacokinetics

Macrogol is largely non-absorbed in the gastrointestinal tract, which allows it to exert its effects locally within the bowel. Due to its high molecular weight, it remains in the intestinal lumen, where it facilitates water retention. Elimination occurs through feces, as it is not metabolized by the body.

Pregnancy

Macrogol can be used during pregnancy if necessary, but caution should be exercised and medical advice sought.

Breast-feeding

Macrogol is generally considered safe to use during breastfeeding.

Storage

Store in a cool, dry place, protected from light. Keep out of reach of children.

Indications

• Constipation
• Faecal impaction
• Bowel preparation prior to surgical procedures or diagnostic tests

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations tailored for pediatric patients.

Adults: Refer to the BNF for specific dosing recommendations based on the condition being treated.

Mechanism of action

Movicol's primary mechanism of action involves the osmotic effects of polyethylene glycol (macrogol), which draws water into the bowel, increasing the water content of the stool. This osmotic effect enhances peristalsis and promotes bowel evacuation.

Pharmacodynamics

The pharmacodynamics of Movicol are characterized by its ability to soften stool and increase its bulk. By retaining water in the intestinal lumen, Movicol helps to stimulate bowel movements and alleviate the symptoms of constipation. It does not stimulate the bowel directly, thus it is less likely to cause dependence compared to stimulant laxatives.

Pharmacokinetics

Movicol is not absorbed systemically; it acts locally within the gastrointestinal tract. Therefore, it has minimal systemic side effects. The elimination of Movicol occurs through feces as it is not metabolized or absorbed into the bloodstream. Its onset of action typically occurs within 24 to 72 hours after administration.

Contra-indications

• Bowel obstruction
• Severe dehydration
• Hypersensitivity to any ingredient in the formulation

Adverse effects

• Abdominal pain
• Bloating
• Diarrhea
• Nausea
• Vomiting
• Electrolyte imbalances

Interactions

• Medications that affect electrolyte balance may interact due to the osmotic nature of the drug
• May reduce absorption of other concomitant oral medications due to rapid transit through the gastrointestinal tract

Precautions

• Use with caution in patients with renal impairment
• Monitor electrolyte levels in patients with underlying electrolyte imbalances
• Assess hydration status regularly in long-term use

Pregnancy

Movicol is generally considered safe for use during pregnancy, but it should be used under medical supervision.

Breast-feeding

Movicol can be used while breastfeeding, but consult a healthcare provider for personalized advice.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

• Powder for oral solution
• Sachets containing macrogol (polyethylene glycol) with electrolytes

Mechanism of action

Ethylene glycol is metabolized by alcohol dehydrogenase to glycoaldehyde, which is then metabolized to glycolic, glyoxylic, and oxalic acids. These acids, along with excess lactic acid are responsible for the anion gap metabolic acidosis. Oxalic acid readily precipitates with calcium to form insoluble calcium oxalate crystals. Tissue injury is caused by widespread deposition of oxalate crystals and the toxic effects of glycolic and glyoxylic acids.